The 10th World Down Syndrome Congress, held in Dublin Ireland, wrapped up over the weekend. According to the website, the theme for this meeting was:
...Lifelong Living and Learning. We have chosen this theme to stress the fact that people with Down syndrome and their families develop right throughout their lives. We are constantly encountering new experiences and personal demands, in circumstances that can be both challenging and fulfilling for each individual, family and community.
The Irish Times reported on research results from David Patterson, a professor at the Department of Biological Sciences at the Eleanor Roosevelt Institute, University of Denver, who has developed a mouse model of trisomy 21 and is developing possible drug treatments that could aid in cognition and memory in people with Down syndrome. The preliminary results (in mice) have been encouraging and he hopes to soon start clinical trials.
Would you be interested in using a medication like this? Do you think that it would be helpful?